Bromfenac Ophthalmic Solution 0.09%
Recall D-0585-2016, part of FDA recall event 73072. See Mayne Pharma USA's company page.
Mayne Pharma Usa started this Class II drug recall on Jan 5, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Jan 13, 2017.
- Classification: Class II
- Started: Jan 5, 2016
- Status: Terminated
Lack of Assurance of Sterility: Failed preservative effectiveness test
- Product
- Bromfenac Ophthalmic Solution 0.09%, a) 2.5 mL bottles (NDC 0378-7110-35) and b) 5 mL bottles (NDC 00378-7109-35), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505
- Quantity
- a) 52034 bottles and b) 22074 bottles
- Lots and codes
- a) Lot numbers: 0378-7110-35 AD4819, Exp. Date: 08-2016; 0378-7110-35 AC7894, Exp. Date: 05-2016; 0378-7110-35 AD2527, Exp. Date: 06-2016; 0378-7110-35 AC6330, Exp. Date: 05-2016; 0378-7110-35 AC2330, Exp. Date: 04-2016 and b) Lot numbers: 0378-7109-35 AD4515, Exp. Date: 04-2016 and 0378-7109-35 AC2328, Exp. Date: 01-2016.
- Distribution
- Nationwide
- Recalling firm
- Mayne Pharma Usa, Greenville, NC, United States
- How the firm notified
- Letter
- FDA classified
- Jan 20, 2016
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports